AbstractÐGalanin is widely distributed throughout the mammalian brain and has been implicated in the regulation of food intake, metabolism and reproductionÐfunctions that are also thought to be under the control of leptin. To investigate the possible role of galanin in mediating the physiological effects of leptin in the mouse, we had three experimental objectives: ®rst, to map the distribution of galanin messenger RNA-expressing cells in the brain of the mouse; second, to assess the effects of leptin on galanin gene expression in areas of the brain thought to be involved in the regulation of body weight and reproduction; and third, to determine whether galanin neurons in these regions express leptin receptor messenger RNA. We found the pattern of galanin messenger RNA expression in the mouse brain to be similar, but not identical, to that in the rat. Leptin treatment (2 mg/g for six days) signi®cantly reduced cellular levels of galanin messenger RNA in the hypothalamic periventricular nucleus of leptin-de®cient obese (ob/ob) mice (P , 0.01) by approximately 30%; however, leptin did not appear to in¯uence the expression of galanin in the arcuate or dorsomedial nucleus of the hypothalamus. Galanin-producing neurons in the arcuate, dorsomedial and periventricular nuclei did not appear to express leptin receptor messenger RNA (P . 0.05).
Galanin is a 29 amino acid neuropeptide that was originally isolated from the porcine gut. 42 In mammals, galanin is widely distributed throughout the central and peripheral nervous systems. 26 One curious observation about galanin's expression in the brain of mammals is its species speci®city, which is particularly evident in the rat and monkey. For example, in the rat there is little or no expression of galanin in the hippocampus but there are abundant galanin-containing cells in the dorsal raphe. 23, 34 In the monkey, however, galanin producing cells are found throughout the hippocampus, yet are absent from the dorsal raphe. 17 To date, there has been no detailed mapping of the distribution of galanin in the mouse brain. Because of the growing importance of the mouse as a genetic model for understanding the brain, it is vital that we know the comparative anatomy of neuropeptide expression in the murine brain and use this information to shed light on the differences and similarities between species. The ®rst objective of this study was to complete a detailed map of the distribution of galanin in the mouse brain and to highlight the common and unique features of galanin's pattern of expression in the mouse compared to that of other mammalian species.
Evidence suggests that galanin plays a role in physiological processes that are regulated by body fat reserves, such as feeding behaviors and reproduction. 3, 7, 36, 45 Information about the status of fat reserves is communicated throughout the body by the adipocyte-derived hormone leptin, which is secreted into the general circulation. The CNS is a major target for leptin's action and long form leptin receptor (Ob-Rb) mRNA is expressed by neurons in distinct anatomical regions of the brain. 9 In the rat, both Ob-Rb and galanin are expressed in hypothalamic nuclei that are involved in regulating food intake and reproductive function, including the arcuate (Arc) and dorsomedial (DMN) nuclei. 9, 24, 34 These observations suggest the possibility that at least some of the effects of body fat stores on feeding and reproduction are linked to leptin's action on galanin-expressing neurons in the hypothalamus; however, hypothalamic interactions between leptin and galaninergic neurons have not yet been addressed in either the rat or mouse.
A second objective of this study was to examine whether galanin is involved in mediating the effects of leptin in the hypothalamus of the mouse. To explore this question, we tested the hypothesis that leptin regulates the activity of galaninergic neurons by evaluating the effects of leptin on galanin gene expression in the leptin-de®cient ob/ob (obese) mouse. Next, having observed that leptin altered the expression of galanin mRNA in the hypothalamic periventricular nucleus (PeN), we tested the hypothesis that leptin acts directly on these cells by examining whether these and other galaninergic neurons in the hypothalamus express ObRb mRNA.
EXPERIMENTAL PROCEDURES

Animals
In Experiment 1, adult male C57BL6/J £ 129 SV mixed strain mice (n 3) bred in the animal colony at the University of Washington were used. In Experiment 2, ®ve-month-old male ob/ob (n 10) and age-matched lean wild-type C57BL/6J mice (n 5) were purchased from Jackson Laboratories (Bar Harbor, ME). In Experiment 3, 90-day-old male C57BL/6J wild-type mice (n 5) were obtained from B&K Universal (Kent, WA). All animals were housed in groups of two to ®ve, unless otherwise stated, and maintained on a 12-h light/dark cycle with lights off at 18.00 h in the animal care facilities of the University of Washington Department of Comparative Medicine. The University of Washington's Animal Care Committee approved all animal procedures in accordance with the NIH Guide to Care and Use of Laboratory Animals. All efforts were made to minimize both the suffering and the number of animals used.
Experimental design
In Experiments 1 and 3, animals were killed by CO 2 asphyxiation, and brains were removed, frozen on dry ice and stored at 2808C. All brains were cryosectioned at 20 mm. In Experiment 2, animals were housed singly prior to the start of the experiment. Ob/ob animals were divided into two groups: one group received a daily i.p. injection of 2 mg/g leptin and was fed ad libitum, the other group received a daily i.p. injection of an equivalent volume of physiological saline and was pair-fed to the leptin-treated animals. Wild-type animals received daily i.p. injections of physiological saline and were fed ad libitum. All injections were given within 1 h before lights off. Food intake and body weight were measured daily. After six days of injections, animals were killed in the afternoon (12.30±15.00 h) by CO 2 asphyxiation, blood was collected by cardiac puncture and the animals were decapitated. Brains were rapidly removed, frozen on dry ice and stored at 2808C. Brains collected for Experiment 1 were sectioned from the olfactory bulb to the caudal medulla; brains collected for Experiments 2 and 3 were sectioned from the medial preoptic area to the mammillary body.
Leptin
Recombinant full-length human leptin protein, generously provided by ZymoGenetics, was produced in Saccharomyces cerevisiae, puri®ed to near homogeneity (.95%) by analytical high-pressure liquid chromatography, and quanti®ed by mass spectroscopy. The control solution for leptin was 50 mM sodium borate (pH 8.0) in 0.9% sodium chloride.
Riboprobe preparation
35
S-labeled mouse galanin probe (Experiment 1). The plasmid vector pGemT-Easy containing a 493 bp cDNA corresponding to the entire coding region of preprogalanin was kindly provided by Dr James Hyde of University of Kentucky. The plasmid was linearized with SacII and transcribed with SP6 to generate a cRNA antisense probe complementary to mouse galanin mRNA. A sense probe was generated by linearizing the plasmid with PstI, and transcribed with T7. The isotopically labeled mouse galanin antisense riboprobe was generated in an in vitro transcription reaction with the following reagents: 25 ml of 12.5 mCi/ml 35 
S-labeled uridine 5
H -triphosphate (UTP), which represents 25% of UTP, and 2 ml cold thio-labeled UTP in a ®nal concentration of 50 mM a-thio-UTP; 2 ml mixture of 50 mM each of ATP, cytosine 5
H -triphosphate (CTP), and guanosine 5
H -triphosphate (GTP); 2 ml RNase block; 3 ml SP6; 2 mg linearized mouse galanin plasmid vector DNA; 2 ml 10 £ transcription buffer (Boehringer Mannheim, Indianapolis, IN); and 10 ml diethl pyrocarbonate (DEPC)-treated water. The transcription reaction was incubated at 378C for 1.5 h. The reaction mixture was then mixed with 1 ml DNase I for 15 min before the reaction was terminated with the addition of 4 ml EDTA and 1 ml tRNA. The probe mixture was brought to a ®nal volume of 50 ml with DEPC-treated water, puri®ed with a Quickspin G-50 Sephadex spin column (Boehringer Mannheim, Indianapolis, IN) and run on a polyacrylamide gel to check for probe integrity. H non-coding sequence. The plasmid was linearized with HindIII for the generation of an antisense probe and with SmaI for the generation of a sense control probe. The isotopically labeled rat galanin riboprobe was generated in an in vitro transcription reaction with the following reagents: 32.4 ml of 12.5 mCi/ml 35 S-labeled UTP, which represents 25% of UTP, and 2.68 ml cold thio-labeled UTP in a ®nal concentration of 50 mM a-thio-UTP; 1.5 ml of 50 mM each of ATP, CTP, and GTP; 1.5 ml RNase block; 3 ml T7; 1.5 mg linearized rat galanin plasmid vector DNA; 1.5 ml dl-dithiothreitol; 3 ml 10 £ Reaction buffer (Ambion, Austin, TX); and 16.5 ml DEPC-treated water. The reaction mixture was incubated at 378C for 1 h and for an additional 35 min after another 3 ml of T7 was added. The reaction mixture was then mixed with DNase I for 15 min before the reaction was terminated with the addition of 6 ml EDTA and 1 ml tRNA. The probe mixture was puri®ed with a Quickspin G-50 Sephadex spin column and run on a polyacrylamide gel to check for probe integrity.
Digoxigenin-labeled rat galanin probe (Experiment 3). A protocol similar to that for digoxigenin-labeled proopiomelanocortin (POMC) probe 4 was used in the preparation of the digoxigenin-labeled rat galanin probe. The reaction mixture consisted of: 2 ml digoxigenin mix; 1 £ reaction buffer; 2 ml RNase blocker; 1 mg DNA; 2 ml T7 polymerase; and 11 ml DEPC-treated water. All ingredients were incubated at 378C for 1 h, treated with 1 ml of 20U DNase for 30 min, and the reaction was terminated with 4 ml EDTA. The probe was puri®ed with a Quickspin G-50 Sephadex spin column and checked with agarose gel electrophoresis. An in situ hybridization assay was performed to determine the optimal working concentration for this digoxigenin-labeled rat galanin riboprobe. 33 P-labeled mouse long-form leptin receptor probe (Experiment 3). The plasmid vector containing a cDNA to mouse ObRb mRNA was kindly provided by Joseph Kuijper at ZymoGenetics. A 1111 bp fragment was cloned into the vector pCR-script Amp SK(1). The plasmid was linearized with SpeI and transcribed with T3 to generate a 537-bp fragment that maps to the intracellular domain of the mouse leptin receptor. The Ob-Rb riboprobe was generated in an in vitro transcription reaction with the following reagents: 0.25 mCi of 33 P-labeled UTP that was dried down; 2 ml each of 0.5 mM ATP, CTP and GTP; 2 ml 10 £ transcription buffer; 1.5 mg linearized plasmid DNA; 40 U T3; 80 U RNase blocker; and 8.5 ml DEPC-treated water to bring the total volume to 20 ml. After 2 h of incubation at 378C, 1 ml tRNA and 4 ml EDTA were added to terminate the reaction. The total volume of the reaction was brought to 45 ml with DEPCtreated water before it was puri®ed with a Quickspin G-50 Sephadex spin column. The probe yield was calculated based on the scintillation counter readings, and the integrity of the probe was con®rmed by acrylamide gel electrophoresis followed by autoradiographic development of photographic ®lm.
Single-and double-label in situ hybridization Experiments 1 and 2. Tissue sections were processed according to a previously described protocol, with some modi®cations. 10 In brief, tissue was ®xed in 4% paraformaldehyde, acetylated, delipidated in chloroform, rehydrated in 95% ethanol and airdried. Tissue sections were then hybridized overnight at 608C with 35 S-labeled mouse (Experiment 1) or rat (Experiment 2) galanin riboprobe at a concentration of 0.25 mg/ml/kb. All slides were treated with RNase and washed with standard saline citrate (SSC) at increasing stringencies, which included two washes in 0.1 £ SSC at 658C. Sections were then dehydrated in an ethanol series and air-dried. All slides were dipped in diluted NTB2 emulsion (Kodak, Rochester, New York) and were exposed for 22 days (Experiment 1) or nine days (Experiment 2), before development with Kodak D-19 developer (Kodak, Rochester, New York).
Experiment 3. Slides were processed for double-label in situ hybridization as previously described, with some modi®cations. 21 Slides were processed initially in a similar fashion to those in experiments 1 and 2. They were then hybridized overnight at 608C with the 33 P-labeled mouse Ob-Rb riboprobe, which was used at 2.5 pmol/ml, and the digoxigenin-labeled rat galanin riboprobe, which was used at 1:300 dilution. After the slides were washed twice in 0.1 £ SSC at 658C, they were incubated with alkaline phosphatase-conjugated digoxigenin antibody (Boehringer Mannheim, Indianapolis, IN) at 1:1000. Next, they underwent a chromagen reaction with Nitro Blue Tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate at 378C for approximately 2 h, until optimal color was achieved. After drying, slides were dipped in 3% parlodion, followed by undiluted Kodak NTB-3 emulsion, and then exposed at 48C for ®ve days. Galanin mRNA-expressing neurons were identi®ed as cells with purple±blue precipitate.
Image analysis
For all three experiments, the atlas of Franklin and Paxinos 12 was used to identify speci®c regions of the mouse brain. The image analyses in Experiments 2 and 3 were performed blindly by a reader who was unaware of the assignment of slides (and sections) to either particular treatment groups or genotypes. Experiment 1. The entire mouse brain, from the olfactory bulb to the caudal medulla, was analysed by re¯ected-light, dark-®eld microscopy for the presence of silver grain clusters (indicating the presence of galanin mRNA-containing cells) in de®ned brain regions. Sections were cut at 20 mm thickness, and approximately 150 sections were examined for each animal. Each brain region with galanin-expressing cells was qualitatively scored for both the number of cells and relative level of galanin mRNA expression. and PeN (0.14 mm to 20.22 mm). These areas were chosen because of their possible involvement in food intake and reproduction. The number of grains per cell, which is a semiquantitative indicator of the amount of mRNA present within a cell, was measured with an automated grain-counting system, as previously described. 5 Only the left half of each brain section was analysed.
Experiment 3. The following areas were included in the analysis: Arc, DMN and PeN. Sections containing digoxigenin-labeled neurons were analysed by an automated image processing system to estimate the percentage of galanin neurons that express Ob-Rb mRNA. The image processing system consisted of a Pixel Grabber video acquisition board (Perceptics Corp., Knoxville, TN) attached to a Macintosh IIfx computer (Apple Computer Corp., Cupertino, CA). The sections were viewed under a Zeiss Axioscope microscope (Zeiss, New York, NY) equipped with a 40 £ epi-illumination dark-®eld objective. Video images were obtained by a Dage model 65 camera (Dage-MIT, Michigan City, IN) attached to the microscope. Digoxigenin-labeled neurons (representing galanin mRNA-containing cells) were ®rst visualized under bright-®eld illumination, and on the corresponding video image, the boundaries of the digoxigenin-labeled cell bodies were outlined. Next, the illumination was switched to dark-®eld, and silver grains (representing Ob-Rb mRNA containing cells) were counted over the outlined neurons as well as over the surrounding area, as previously described. 4 
Control experiments
In separate experiments, the identity and integrity of the radioactively labeled galanin and Ob-Rb cRNA probes were veri®ed by polyacrylamide gel electrophoresis (PAGE) against known standards. Control experiments conducted with sense riboprobes revealed no speci®c labeling. In a separate experiment, the identity and integrity of the digoxigenin-labeled galanin cRNA probe was veri®ed by agarose gel electrophoresis against a known standard and was shown to label cells in virtually identical anatomical regions of the brain as did the 35 S-labeled probe.
Statistical analysis
In Experiment 2, the number of galanin mRNA-expressing cells and the mean number of grains/cell in each examined region were calculated for every animal. For each area, the cell counts and mean number of grains/cell were analysed by ANOVA, followed by Fisher's PLSD test, when the ANOVA indicated a signi®cant difference between groups.
In Experiment 3, signal-to-background ratios (SBRs) were calculated for all of the galanin mRNA-containing neurons that were measured. For each area, a one-sample sign test was used to determine whether the SBRs for the cells in that area were signi®cantly greater than one (one is the value that would be expected if there were no speci®c signal). 39 Results of statistical tests were considered signi®cant at P , 0.05.
RESULTS
Galanin messenger RNA distribution in the brain (Experiment 1)
Galanin mRNA-containing cells were identi®ed as clusters of silver grains in anatomically distinct nuclei throughout the CNS of the mouse ( Fig. 1; Table 1 ). In the olfactory bulb, moderate numbers of labeled cells were found throughout the glomerular layer, but few cells were seen elsewhere. The prosencephalon contained numerous galaninergic cells, from the diagonal band of Broca to the supramammillary nucleus. Labeling was generally moderate in the telencephalon, with the highest numbers of cells found in the bed nucleus of the stria terminalis, the horizontal limb of the diagonal band of Broca and the subfornical organ. The dentate gyrus had moderate labeling, primarily in the caudal polymorphic layer (Fig. 1D) . Several divisions of the amygdala had only modest cell counts; however, these few cells were intensely labeled (Fig. 1C) . Virtually no labeling was seen in the cortex, nucleus accumbens or striatum.
In the diencephalon, the thalamus contained relatively few galanin cells, but a continuous ring of weakly labeled cells was seen extending from the central lateral to the central medial thalamic nuclei. The hypothalamus contained the largest number and densest labeling of any forebrain region. Most divisions of the preoptic area (POA) were intensely labeled, particularly in the medial and ventromedial divisions (Fig. 1A) . The area surrounding the rostral third ventricle had many highly expressing cells, most notably in the anteroventral PeN and throughout the rostral PeN (Fig. 2) . The supraoptic, perifornical, paraventricular (PVN) and Arc nuclei all contained moderate numbers of cells, while the lateral hypothalamic area had scattered cells throughout its rostrocaudal extent (Fig. 1B) . The most densely labeled nucleus of the hypothalamus was the DMN, with intensely labeled, tightly packed cells found in all divisions, most notably in the rostral portions (Fig. 1B) .
The mesencephalon contained the fewest number of galanin-producing cells in the brain, with scattered cells noted in the Edinger±Westphal and oculomotor nuclei, and only occasional-labeled cells observed elsewhere. In the rhombencephalon, most noradrenergic cell groups contained galanin mRNA, including A7, A5, A1 and A2. The locus coeruleus (LC) contained large numbers of tightly clustered, intensely labeled cell bodies, throughout its rostrocaudal extent (Fig. 1E) . Many densely labeled cells were also found in the vagal complex, most obviously in the solitary tract nucleus (NTS) and the dorsal motor nucleus of vagus (DMV; Fig. 1F ). Distinct, small groups of cells were noted in the inferior salivatory, paragigantocellular and lateral reticular nuclei. No speci®c labeling was detected in the cerebellum.
Regulation of galanin messenger RNA by leptin (Experiment 2)
In the PeN, cellular levels of galanin mRNA were signi®cantly reduced in ob/ob mice given leptin compared to vehicle-treated, pair-fed controls (leptintreated ob/ob: 18.8^1.9 vs pair-fed ob/ob: 27.8^3.5; P , 0.01; Figs 2, 3) . Levels of galanin mRNA in the PeN of lean controls were similar to those in the leptin-treated ob/ob animals (lean controls: 18.7^0.4 vs leptin-treated ob/ob: 18.8^1.9; Figs 2, 3 ). There were no differences in the total number of galanin mRNA-expressing cells among the experimental groups (data not shown). Leptin treatment did not signi®cantly alter levels of galanin mRNA in either the Arc or DMN of ob/ob mice, and there were no signi®cant differences in cellular levels of galanin mRNA between ob/ob mice and lean controls in either of these areas (Fig. 3) .
Co-localization of galanin and ob-Rb messenger RNAs (Experiment 3)
The distribution of Ob-Rb mRNA that we observed in the hypothalamus was consistent with earlier reports in the mouse, 24 with abundant expression being evident in the Arc and DMN, where there are numerous galaninergic cells (Fig. 4) . 34 However, visual inspection of these hypothalamic nuclei revealed only the rare galanin mRNA-expressing cell in either the Arc or DMN that appeared to coexpress Ob-Rb mRNA. Based on a conservative threshold of SBRs 6, less than 5% of digoxigenin-labeled galaninergic neurons in the Arc, DMN or PeN could be said to coexpress Ob-Rb and statistical analysis failed to provide any clear evidence for co-labeling in any of these hypothalamic nuclei.
DISCUSSION
Comparative distribution and intensity of galanin expression among species
Results of the distribution analysis for galanin mRNAexpressing cells in the brain of the mouse reveal a pattern of galanin expression similar, but with several important differences, to that previously described for the rat. 6, 14, 34 As in the rat, the highest numbers of galanin mRNAexpressing cells were observed in the diencephalon and rhombencephalon, with moderate labeling in the telencephalon and mesencephalon. In the forebrain, the presence of galanin mRNA within all of the major basal forebrain areas that contain cholinergic neurons suggests that galanin plays a similar role in modulating acetylcholine synthesis and release in the mouse as has been postulated for the rat and primate (reviewed in Refs 27 and 29). A notable and curious ®nding in the mouse is the apparent lack of galanin message in the cortex and striatumÐ areas that have been reported to contain both galanin mRNA and peptide in primates (Cebus monkeys, baboons and humans) 17 and rats. 6, 23, 41 One major difference between several of these studies and ours is that the mice used in our study did not receive colchicine pretreatment, whereas the majority of rat studies have used colchicine to enhance galanin peptide levels. Colchicine has been shown to induce the expression of neuropeptide genes, including galanin, 6 and since the studies in the rat where galanin has been reported to be expressed in the cortex and striatum entailed colchicine as a pretreatment, any direct comparison between the results we have obtained in the mouse and these earlier Adult male C57BL6/J £ 129SV mice (n 3) brains were examined by using 35 Slabeled riboprobes complementary to mouse galanin mRNA. In situ hybridization assays were performed from the olfactory bulb through the brain to the caudal extent of the medulla, and all sections were analysed for the presence of silver grain clusters representing galanin-expressing cells. All anatomical areas listed are according to the atlas of Franklin and Paxinos. published studies in the rat must be viewed cautiously. Studies in the rat examining the distribution of galanin mRNA in non-colchicine-treated animals report little if any galanin gene expression in these areas. 14, 34 However, in the primate studies, where colchicine was not used, galanin appears to be expressed robustly in the striatum, 17 suggesting an unequivocal difference in distribution of galanin mRNA-containing cells between primate and mouse. Another notable observation in the mouse is the modest, yet highly reproducible, presence of galanin mRNA within the dentate gyrus of the hippocampus. This contrasts with studies of this region in the rat (without colchicine pretreatment), where galanin mRNA is not apparently expressed and the peptide is detected only with the use of certain antibodies. 6, 14, 22, 34, 41 In primate studies, galanin-containing neurons are found throughout the hippocampal formation, in contrast to the discrete localization in the dentate gyrus found in our study of the mouse. 17 Within the hypothalamus, most nuclei exhibited at least moderate labeling, with notable exceptions being the ventromedial and suprachiasmatic nuclei, which had no detectable signal for galanin mRNA. In the mouse, relatively few cells with modest intensity of labeling were observed in both the parvocellular and magnocellular regions of the PVN, which contrasts with the reports of high levels of galanin mRNA and peptide seen in the PVN of the rat. 23, 34, 41 However, in complete accord with observations in the rat, we observed very high numbers of labeled cells in the DMN, PeN and POA, underscoring the general importance of these nuclei as major sources of hypothalamic galanin. As a step towards understanding the functional signi®cance of these galaninergic cells, it would be interesting to learn whether these cells coexpress other peptides. Rajendren et al. have recently shown in the mouse that gonadotropin-releasing hormone neurons within the POA contain signi®cant amounts of galanin and that this co-localization phenomenon is sexually dimorphic and sex-steroid dependent, 31 corroborating earlier ®ndings in the rat. 25 The results of our analysis
Galanin mRNA in mouse brain and regulation by leptin in hypothalamus 429 Fig. 2 . Photomicrographs of galanin-mRNA containing cells in the periventricular nucleus of (A) an ob/ob mouse treated with leptin, (B) a pair-fed ob/ob mouse treated with saline, and (C) a lean control mouse. 3V, third ventricle. The groups consisted of normal mice (lean, vehicle-treated and ad libitum fed; n 4) and leptin-de®cient mice (ob/ob) either treated with leptin and allowed to feed ad libitum (n 5), or treated with vehicle and given the same amount of food (pair-fed) as consumed by the leptin-treated group (n 5). There were no signi®cant differences among groups in any of the areas except the PeN where vehicle-treated ob/ob mice had signi®cantly higher levels of galanin mRNA. Bars represent means^S.E.M.
of galanin mRNA expression in the hypothalamus of the mouse are in good agreement with a recent report of galanin immunoreactivity in the murine basal forebrain, 32 although the relative abundance of galanin peptide reported is at slight variance with our mRNA ®ndings in various regions. It is conceivable that this variance results from methodological differences between the two studies; alternatively, it is possible that it simply re¯ects the fact that levels of mRNA and peptide are regulated differentially in some brain regions, as has been reported in the hypothalamus for cells that are actively secreting peptides. 40 The midbrain of the mouse contained very little galanin mRNA, which is consistent with ®ndings in primates where no galanin-containing cells are observed. 17 Our results in the mouse also concur with those in the rat, except in the dorsal raphe, where in the rat (but not the mouse), there are abundant galanin-producing cells, 23, 34, 41 suggesting that the putative interactions between galanin and the serotonergic system might be highly species speci®c (reviewed in Ref. 13 ).
In the brainstem of the mouse, galanin mRNA was particularly abundant in two areas, the LC and dorsal vagal complex. In the LC, galanin mRNA was nearly as abundant as in the DMN and POA of the hypothalamus, in agreement with previous studies in the rat. Many scattered cell groups were found in other parts of the brainstem, but the only other large population of galanin mRNA-expressing cells was in the vagal complex, notably in the dorsal NTS and DMV. The distribution of galanin mRNA-containing cells in the NTS of the mouse accords well with previously published reports in other species. 17, 41 However, the robust population of galanin mRNA-expressing cells we observed in the DMV is apparently unique to the mouse, since studies in the rat and primates report only low numbers of galanin-containing cell bodies in this region, despite the appearance of abundant ®ber tracts. 17, 23, 34, 41 Although the functional signi®cance of this observation is unknown, one plausible hypothesis would be that in the mouse, galanin modulates preganglionic parasympathetic neurons.
The absence of detectable levels of galanin mRNA in areas such as the cerebellum, cortex and striatum of the mouse, which in other species have been reported to contain galanin, may re¯ect genuine species differences. However, it is also possible that differences between laboratories in the relative sensitivity in the methods used for detecting galanin mRNA account for the apparent differences in the distribution pro®le among species.
Regulation of galanin gene expression by leptin
Because both galanin and leptin are thought to play an important role in the regulation of feeding and reproduction, a primary goal of this study was to investigate whether galanin might be involved in mediating the effects of leptin, particularly in the hypothalamus. We found ®rst that levels of galanin mRNA were approximately 50% higher in the PeN of leptin-de®cient ob/ob mice compared to wild-type controls and second that treatment of ob/ob mice with leptin reduced levels of galanin mRNA in the PeN to that found in wild-type controls. Leptin did not appear to affect galanin gene expression in either of the two other hypothalamic areas studied (Arc and DMN). The apparent lack of regulation of galanin expression by leptin in these two nuclei parallels ®ndings in the rat, which suggests that outside the anterior PVN/PeN, galanin does not play a signi®cant role in the regulation of feeding, metabolism and adiposity (reviewed in Ref. 18 ).
The signi®cance of leptin's regulation of galanin gene expression in the PeN is uncertain. In the rat, the anterior portion of the hypothalamic PVN is the site where galanin is thought to be most effective in the regulation of ingestive behaviors. 19 Speci®cally, galanin in the PVN preferentially increases fat ingestion. 20, 43 In addition, leptin administration reduces galanin expression in the PVN of the rat. 35 Together, these ®ndings suggest that leptin decreases food intake in the rat partially by reducing galanin-induced fat ingestion. Owing to the generally low abundance of galanin mRNA in the PVN of the mouse, we were unable to assess the possible effects of leptin on galanin expression in this region. However, it is conceivable that the population of leptin-responsive galaninergic neurons in the PeN of the mouse is homologous to those in the anterior PVN/PeN region of the rat.
Our observation that galanin gene expression is upregulated in a subpopulation of neurons in the leptinde®cient ob/ob mouse is consistent with the notion that galanin neurons are involved in the regulation of body weight. Galanin has been shown to act centrally to increase feeding and reduce sympathetic activityÐ actions that would generally decrease metabolism. 2, 28, 36 Thus, it seems plausible that the up-regulation of galaninergic activity in the ob/ob mouse contributes to C. C. Cheung et al. 430 Fig. 4 . Photomicrograph illustrating the lack of Ob-Rb mRNA expression in hypothalamic galaninergic neurons. White silver grains mark the presence of Ob-Rb mRNA (arrowheads) and digoxigenin-labeled galanin mRNA-expressing neurons appear as darkly stained cells (arrows). A neuron that expresses both Ob-Rb mRNA and galanin mRNA is identi®ed as having silver grain clusters superimposed on a darkly stained cell. Scale bar 20 mm.
the obese phenotype of these animals by stimulating hyperphagia and slowing metabolic activity. Furthermore, galanin has been shown to induce a natural preference for fat consumption (reviewed in Ref. 18) , and indeed, the ob/ob mouse displays a distinct preference for fat in its diet. 33 Finally, leptin administration to ob/ob mice reduces food intake and increases sympathetic activity, 8, 16, 30 both of which could be partly attributable to the reduced expression of galanin. If some of the effects of leptin on body weight in the mouse are mediated by galanin, our results suggest that galaninergic neurons in the PeN are those most likely to be responsible for producing these effects.
Coexpression of galanin and the leptin receptor
In addition to investigating the effects of leptin on galanin gene expression, we sought to determine whether leptin acts directly on galanin neurons by searching for neurons that express both galanin and Ob-Rb mRNAs. We reasoned that the galanin-expressing neurons most likely to express Ob-Rb would be those residing in the PeN and found to be regulated by leptin. However, since it is plausible that leptin regulates other gene products in galanin neurons, we explored the possibility that galaninergic neurons in other hypothalamic nuclei might also express Ob-Rb. Again, we focused on the Arc and DMN in the hypothalamus because of their putative role in the regulation of food intake. Quantitative analysis of the hypothalamic nuclei failed to reveal the presence of Ob-Rb in galaninergic neurons, although subjective visual inspection suggested that an occasional cell appeared to coexpress both galanin and Ob-Rb mRNAs. This low level of co-expression is in concert with observations in the rat that only a few galanincontaining neurons in the Arc display leptin receptor immunoreactivity. 15 We cannot exclude the possibility that some galanin neurons do express Ob-Rb mRNA and that only a few Ob-Rb-expressing galanin neurons are needed to mediate leptin's action through galanin. However, galanin gene expression in the PeN may also be regulated indirectly by leptin through other leptin-sensitive signaling systems. For example, insulin has been shown to inhibit galanin expression in the hypothalamus; 46 therefore, it seems possible that the increased sensitivity to insulin, occurring as a result of leptin administration, facilitates insulin's inhibitory action on galanin gene expression. 1, 37 Another possibility is that leptin's effects on galanin-expressing neurons in the PeN are mediated by other Ob-R-expressing neurons. In this scenario, POMC neurons in the Arc are plausible candidates, since they are regulated by leptin, express leptin receptor mRNA and heavily innervate the PeN. 4, 11, 38, 44 In summary, galanin is one of many neuropeptides implicated in the regulation of body weight and reproduction, and thus may mediate some of leptin's effects on these processes. Galanin-expressing neurons are widely distributed throughout the brain of the mouse, including the DMN and Arc, which are known to be involved in the regulation of body weight and reproduction. Nevertheless, we could adduce no evidence for a leptin effect on the expression of galanin in neurons in these two areas. Rather, our results point to the hypothalamic PeN as a potential primary target for leptin's actions. The observation that leptin inhibits the expression of galanin mRNA in the PeN suggests that neurons in this region play a role in mediating the effects of leptin on one or more basal regulatory processes. Although the identity of those processes cannot be determined from these results, the regulation of body weight and reproduction are possibilities. Since galanin-expressing neurons in the PeN do not appear to express Ob-Rb, information about circulating levels of leptin must reach these neurons indirectly, either by some leptin-regulated hormone(s) or through other hypothalamic neurons that do express Ob-Rb. The functional signi®cance of leptin's interaction with galaninexpressing neurons in the PeN remains to be determined.
